The grant will be awarded to qualified academic laboratories to be invested in drug discovery research, specifically focused on medicinal chemistry and/or drug target screening in hematological malignancies. The applications will be peer reviewed by a special committee to be launched in July 2017 and the grants are anticipated to be for two years.